# Comparison of Pharmacokinetic Profiles of 3 New Nicotine Gum Formulations With a Reference Gum

> **NCT02356913** · PHASE1 · COMPLETED · sponsor: **Fertin Pharma A/S** · enrollment: 15 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** Nicotine gum

## Key facts

- **NCT ID:** NCT02356913
- **Lead sponsor:** Fertin Pharma A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2015-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02356913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02356913, "Comparison of Pharmacokinetic Profiles of 3 New Nicotine Gum Formulations With a Reference Gum". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02356913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*